Cargando…
External Validation of the Lupus Multivariable Outcome Score for Systemic Lupus Erythematosus Trials
OBJECTIVE: Development of new systemic lupus erythematosus (SLE) treatments requires an effective responder index. Toward this end, we have recently developed a new Lupus Multivariable Outcome Score (LuMOS) to optimize discrimination between actively treated patients and those on placebo. We now rep...
Autores principales: | Abrahamowicz, Michal, Abrahamowicz, Maria Izabela, Lipsky, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555192/ https://www.ncbi.nlm.nih.gov/pubmed/35962577 http://dx.doi.org/10.1002/acr2.11451 |
Ejemplares similares
-
Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012) -
B cell abnormalities in systemic lupus erythematosus
por: Grammer, Amrie C, et al.
Publicado: (2003) -
Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision‐Making in Systemic Lupus Erythematosus Treatment?
por: Almeida‐Brasil, Celline C., et al.
Publicado: (2022) -
The Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus
por: Ren, Jingjing, et al.
Publicado: (2018) -
Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)